Preliminary unaudited full-year 2025 net revenue related to U.S. sales of VYKAT™ XR since second quarter launch expected to be in a range of $189 million to $191 million. Preliminary unaudited fourth ...
Background Patients with severe aortic stenosis (AS) are at high risk of mortality, regardless of symptom status. Despite ...
I reassured him and sent him to get another blood specimen drawn without a tourniquet. Why? Because I suspected that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback